<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: The <z:mpath ids='MPATH_270'>adenoma</z:mpath> detection rate (ADR) in screening colonoscopy is higher than original cost-effectiveness models estimated </plain></SENT>
<SENT sid="1" pm="."><plain>Future <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) risk is decreased once the ADR is 20%, but it is unclear how much additional protection is provided with higher ADRs </plain></SENT>
<SENT sid="2" pm="."><plain>We modeled the impact of a high ADR on future <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk and surveillance colonoscopy burden </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We created three hypothetical scenarios for 100,000 average-risk individuals undergoing screening colonoscopy at age 50: (i) 20% ADR with 30% future <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk reduction; (ii) 50% ADR with 30% future <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk reduction; and (iii) 50% ADR with 50% future <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk reduction </plain></SENT>
<SENT sid="4" pm="."><plain>After colonoscopy, patients could have high-risk or low-risk <z:mpath ids='MPATH_270'>adenomas</z:mpath>, or no <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: When the ADR increases from 20% to 50% but no additional <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cases are prevented, future <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk for each group is still reduced, because lower-risk patients migrate into apparently higher-risk groups (the Will Rogers phenomenon) </plain></SENT>
<SENT sid="6" pm="."><plain>Future risk is further reduced if a 50% ADR leads to greater protection from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>However, despite the reductions in group-specific and overall future <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk, 34,635 additional surveillance colonoscopies are performed before the cohort is 60 years old when the ADR is 50% compared with 20% </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: If current surveillance practices continue along with high ADRs, screening colonoscopy may not remain cost-effective </plain></SENT>
</text></document>